ADACEL-POLIO susp inj a aiguille ser pré 0.5 ml
7680681100010
CH-68110
J07CA02
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6811001
- CPT
- -
- Packaging group
- 1 x 0.5 ml
- Unit
- Fertigspritze(n)
- Composition
- toxoidum diphtheriae min. 2 U.I., toxoidum tetani min. 20 U.I., toxoidum pertussis 2.5 µg, haemagglutininum filamentosum 5 µg, pertactinum 3 µg, fimbriae types 2 et 3 5 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminii phosphas corresp. aluminium 0.33 mg, phenoxyethanolum, ethanolum 1.01 mg, polysorbatum 80, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp. ethanolum 0.3 % V/V, residui: formaldehydum, glutaralum, streptomycinum, neomycinum, polymyxinum B, albuminum seri bovis.
Articles (1)
Adacel-Polio 0.5 ml, suspension injectable en seringue préremplie
suspension
1 x 0.5 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.5 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
3.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
5.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
29.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
7.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
26.0 U | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.33 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
1.01 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
Reimbursement information
Public price
CHF 42.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2023
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 68110
- Drug name
- Adacel-Polio, suspension injectable en seringue préremplie
- Galenic form
- INJFS
- ATC Code
- J07CA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/08/2022
- Authorization expiration date
- 25/08/2027
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ADACEL-POLIO susp inj a aiguille ser pré 0.5 ml
- Description (DE)
- ADACEL-POLIO Inj Susp m Nadel Fertspr 0.5 ml
- Market launch
- 26/08/2022
- Narcotic (BTM)
- No